Research ArticleArticle
Low versus High-dose Iloprost Therapy Over 21 Days in Patients with Secondary Raynaud’s Phenomenon and Systemic Sclerosis: A Randomized, Open, Single-center Study
ANNEGRET KAWALD, GERD R. BURMESTER, DÖRTE HUSCHER, CORD SUNDERKÖTTER and GABRIELA RIEMEKASTEN
The Journal of Rheumatology September 2008, 35 (9) 1830-1837;
ANNEGRET KAWALD
GERD R. BURMESTER
DÖRTE HUSCHER
CORD SUNDERKÖTTER
GABRIELA RIEMEKASTEN
In this issue
The Journal of Rheumatology
Vol. 35, Issue 9
1 Sep 2008
Low versus High-dose Iloprost Therapy Over 21 Days in Patients with Secondary Raynaud’s Phenomenon and Systemic Sclerosis: A Randomized, Open, Single-center Study
ANNEGRET KAWALD, GERD R. BURMESTER, DÖRTE HUSCHER, CORD SUNDERKÖTTER, GABRIELA RIEMEKASTEN
The Journal of Rheumatology Sep 2008, 35 (9) 1830-1837;
Low versus High-dose Iloprost Therapy Over 21 Days in Patients with Secondary Raynaud’s Phenomenon and Systemic Sclerosis: A Randomized, Open, Single-center Study
ANNEGRET KAWALD, GERD R. BURMESTER, DÖRTE HUSCHER, CORD SUNDERKÖTTER, GABRIELA RIEMEKASTEN
The Journal of Rheumatology Sep 2008, 35 (9) 1830-1837;